Fig. 4From: TLC599 in patients with osteoarthritis of the knee: a phase IIa, randomized, placebo-controlled, dose-finding studyThe mean change in WOMAC-Function scores through week 24. *p < 0.05. LS, least squares; SE, standard errorBack to article page